23 results on '"Ian Ganly"'
Search Results
2. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer
- Author
-
Daniel W. Scholfield, Conall W. Fitzgerald, Bayan Alzumaili, Alana Eagan, Bin Xu, German Martinez, R. Michael Tuttle, Ashok R. Shaha, Jatin P. Shah, Richard J. Wong, Snehal G. Patel, Ronald A. Ghossein, and Ian Ganly
- Subjects
Oncology ,Surgery - Published
- 2023
3. Well-Differentiated Thyroid Cancer: Who Should Get Postoperative Radiation?
- Author
-
Dauren Adilbay, Avery Yuan, Paul B. Romesser, Richard J. Wong, Jatin P. Shah, Ashok R. Shaha, Michael R. Tuttle, Snehal Patel, Nancy Y. Lee, and Ian Ganly
- Subjects
Oncology ,Surgery - Published
- 2022
4. Is a Prophylactic Central Compartment Neck Dissection Required in Papillary Thyroid Carcinoma Patients with Clinically Involved Lateral Compartment Lymph Nodes?
- Author
-
Marlena McGill, Ian Ganly, Snehal G. Patel, Laura Y. Wang, Richard J. Wong, Jatin P. Shah, Ashok R. Shaha, R. Michael Tuttle, and Victoria Harries
- Subjects
Adult ,medicine.medical_specialty ,medicine.medical_treatment ,Article ,Thyroid carcinoma ,03 medical and health sciences ,0302 clinical medicine ,Surgical oncology ,medicine ,Humans ,Thyroid Neoplasms ,Thyroid cancer ,business.industry ,Thyroid ,Thyroidectomy ,Neck dissection ,medicine.disease ,Dissection ,medicine.anatomical_structure ,Oncology ,Thyroid Cancer, Papillary ,030220 oncology & carcinogenesis ,Neck Dissection ,030211 gastroenterology & hepatology ,Surgery ,Lymph Nodes ,Lymph ,Radiology ,business - Abstract
BACKGROUND: The 2015 American Thyroid Association guidelines state that a prophylactic central compartment neck dissection (PCND) should be considered for patients with papillary thyroid carcinoma (PTC) and clinically involved lateral neck lymph nodes (cN1b). The aim of our study was to determine the rate of central neck recurrence in select cN1b patients, with no evidence of clinically involved central compartment lymph nodes, treated without a PCND. METHODS: After institutional review board approval, adult PTC patients with cN1b disease who were treated with a total thyroidectomy and lateral neck dissection were identified from an institutional database of 6,259 patients who underwent initial surgery for well-differentiated thyroid carcinoma from 1986 to 2015. Patients with gross extrathyroidal extension, distant metastases, and no pre-operative imaging were excluded. Patients with evidence of clinically involved central compartment lymph nodes, on pre-operative imaging or intra-operative evaluation, were also excluded. One hundred fifty-two cN1b patients were included and categorized into non-PCND and PCND groups. Central neck recurrence-free probability (CNRFP) was calculated using the Kaplan-Meier method and log-rank tests. RESULTS: One hundred three patients (67.8%) did not have a PCND. With a median follow-up of 65 months, the 5- and 10-year CNRFP was 98.4% in the non-PCND group and 93.6% in the PCND group (p = 0.133). CONCLUSIONS: Select PTC patients with cN1b disease but no evidence of clinically involved central compartment lymph nodes, on pre-operative imaging and intra-operative evaluation, appear to have a low rate of central neck recurrence. These patients may not require or benefit from a PCND.
- Published
- 2020
5. Well-Differentiated Thyroid Cancer: Who Should Get Postoperative Radiation?
- Author
-
Dauren, Adilbay, Avery, Yuan, Paul B, Romesser, Richard J, Wong, Jatin P, Shah, Ashok R, Shaha, Michael R, Tuttle, Snehal, Patel, Nancy Y, Lee, and Ian, Ganly
- Subjects
Iodine Radioisotopes ,Thyroid Cancer, Papillary ,Humans ,Radiotherapy, Adjuvant ,Thyroid Neoplasms ,Neoplasm Recurrence, Local ,Aged ,Retrospective Studies - Abstract
The mainstay of treatment of well-differentiated thyroid cancer (WDTC) is surgery followed by adjuvant radioactive iodine therapy. Postoperative radiation therapy (PORT) is rarely used.The aim of our study was to report our experience of patients with WDTC who were selected to receive PORT.After Institutional Review Board approval, patients who received PORT were identified from a departmental database of 6259 patients with WDTC treated with primary surgery from 1986 to 2015. We carried out propensity matching to compare outcomes with a cohort of patients who did not receive PORT. The main outcome of interest was central neck recurrence-free probability (CNRFP), while secondary outcomes were lateral neck recurrence-free probability (LNRFP), disease-specific survival (DSS), and overall survival (OS).From 6259 patients, 32 (0.5%) patients with a median age of 65.2 years received PORT. Tall-cell variant papillary thyroid carcinoma was the most common pathology (45%). Patients who received PORT had no difference in CNRFP compared with patients treated without PORT (10-year CNRFP 88% vs. 73%; p = 0.18). Furthermore, patients who received PORT had superior LNRFP (10-year LNRFP 100% vs. 62%; p = 0.001) compared with the no-PORT cohort. Despite this, patients who received PORT had similar DSS (71% PORT vs. 75% no-PORT) and OS (65% PORT vs. 58% no-PORT group) as the no-PORT cohort.Our data show that select patients who received PORT had improved locoregional recurrence-free probability; however, this did not translate into improved DSS and OS. At our institution, we recommend the use of PORT only in highly selected patients with locally advanced primary tumors who are deemed to have a high risk of central neck recurrence for which salvage surgery would result in unacceptable risk to the airway.
- Published
- 2022
6. New Insights on the Importance of the Extent of Vascular Invasion in Encapsulated Angio-invasive Follicular Thyroid Carcinoma
- Author
-
Danielli Matsuura and Ian Ganly
- Subjects
Oncology ,Surgery - Published
- 2022
7. ASO Visual Abstract: Well Differentiated Thyroid Cancer-Who Should get Postoperative Radiation?
- Author
-
Dauren Adilbay, Avery Yuan, Paul B. Romesser, Richard J. Wong, Jatin P. Shah, Ashok R. Shaha, Michael R. Tuttle, Snehal Patel, Nancy Y. Lee, and Ian Ganly
- Subjects
Oncology ,Surgery - Published
- 2022
8. Prophylactic Lateral Neck Dissection for Medullary Thyroid Carcinoma is not Associated with Improved Survival
- Author
-
Aradhya Nigam, Murray F. Brennan, Marinela Capanu, R. Michael Tuttle, Philip M. Spanheimer, Ashok R. Shaha, Ian Ganly, Brian R. Untch, Joanne F. Chou, Richard J. Wong, and Ronald Ghossein
- Subjects
medicine.medical_specialty ,Medullary cavity ,medicine.medical_treatment ,Article ,Thyroid carcinoma ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Cumulative incidence ,Thyroid Neoplasms ,Retrospective Studies ,Proportional hazards model ,business.industry ,Thyroidectomy ,Dissection ,Oncology ,Calcitonin ,030220 oncology & carcinogenesis ,Lymphatic Metastasis ,Neck Dissection ,030211 gastroenterology & hepatology ,Surgery ,Radiology ,Lymph ,Neoplasm Recurrence, Local ,business - Abstract
BACKGROUND: Patients with medullary thyroid carcinoma (MTC) often receive lateral lymph node dissection with total thyroidectomy when calcitonin levels are elevated, even in the absence of structural disease, but the effect of this intervention on disease specific outcomes is not known. METHODS: We retrospectively reviewed patients from 1986 to 2017 who underwent thyroidectomy with curative intent for MTC at our institution. The association of disease specific survival (DSS) and clinicopathologic features was examined using univariate and multivariate Cox regression. RESULTS: We identified 316 patients who underwent curative resection for medullary thyroid carcinoma. Overall and disease specific survival were 76% and 86% at 10-years. To investigate the effect of prophylactic ipsilateral lateral lymph node dissection, we analyzed 89 patients without known structural disease in the neck lymph nodes at the time of resection and preoperative calcitonin > 200 pg/ml, of which 45 had an ipsilateral lateral lymph node dissection (LND) and 44 did not. There were no differences in tumor size or preoperative calcitonin levels. There was no difference at 10 years in cumulative incidence of recurrence in the neck (20.9% LND vs 30.4% no LND, p=0.46), cumulative incidence of distant recurrence (18.3% vs 18.4%, p=0.97), disease specific survival (86% vs 93%, p=0.53), or overall survival at (82% vs 90%, p=0.6). CONCLUSION: Lateral neck dissection in the absence of clinical or radiologic abnormal lymph nodes is not associated with improved survival in patients with MTC.
- Published
- 2020
9. Long-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid Carcinoma
- Author
-
Joanne Chou, R. Michael Tuttle, Richard J. Wong, Brian R. Untch, Ronald Ghossein, Philip M. Spanheimer, Ashok R. Shaha, Marinela Capanu, and Ian Ganly
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Multiple Endocrine Neoplasia Type 2a ,Kaplan-Meier Estimate ,Gastroenterology ,Article ,03 medical and health sciences ,0302 clinical medicine ,Carcinoembryonic antigen ,Internal medicine ,medicine ,Carcinoma ,Humans ,Cumulative incidence ,Thyroid Neoplasms ,Child ,Aged ,biology ,business.industry ,Proportional hazards model ,Medullary thyroid cancer ,Cancer ,Neck dissection ,Middle Aged ,medicine.disease ,Oncology ,Calcitonin ,030220 oncology & carcinogenesis ,Carcinoma, Medullary ,Child, Preschool ,biology.protein ,Thyroidectomy ,Neck Dissection ,030211 gastroenterology & hepatology ,Surgery ,Neoplasm Recurrence, Local ,business - Abstract
Long-term outcomes after curative resection in patients with germline RET mutations and medullary thyroid cancer (MTC) are highly variable and mutation-specific oncologic outcomes are not well-described. Sixty-six patients identified from 1986 to 2017 from a single-institution cancer database were assessed for recurrence and survival using Kaplan–Meier estimates, and correlated with clinicopathologic features using log-rank or Cox proportional hazards. Median follow-up was 9.3 years (range 0.3–31.5), median tumor diameter was 1.5 cm (range 0.1–7.5), and preoperative calcitonin was known in 41 patients [median 636 (range 0–9600)]. Overall survival (OS) of the cohort was 94% at 10 years, the cumulative incidence of locoregional recurrence was 38% at 10 years, and 19/24 (79%) patients underwent repeat neck operation. The cumulative incidence of distant recurrence was 27% at 10 years. Predictors of distant recurrence were tumor size, positive lymph nodes, and pre- and postoperative carcinoembryonic antigen, but not calcitonin. M918T mutation-bearing patients had 10-year distant recurrence-free survival of 0%, compared with 83% in all other patients (p
- Published
- 2019
10. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer
- Author
-
Snjezana Dogan, Frank L. Palmer, N. Gopalakrishna Iyer, Jatin P. Shah, Nancy Y. Lee, Rahmatullah Rahmati, Snehal G. Patel, Iain J. Nixon, and Ian Ganly
- Subjects
Adult ,Male ,Oncology ,medicine.medical_specialty ,Disease ,Article ,Pharyngectomy ,Surgical oncology ,Internal medicine ,medicine ,Carcinoma ,Humans ,Head and neck ,Papillomaviridae ,Survival rate ,Aged ,Neoplasm Staging ,Aged, 80 and over ,business.industry ,HPV Positive ,Papillomavirus Infections ,virus diseases ,Cancer ,Middle Aged ,Prognosis ,medicine.disease ,female genital diseases and pregnancy complications ,Survival Rate ,Oropharyngeal Neoplasms ,Cohort ,Carcinoma, Squamous Cell ,Female ,Surgery ,Neoplasm Grading ,business ,Follow-Up Studies - Abstract
Oropharyngeal cancers (OPC) secondary to human papillomavirus (HPV) infections likely represent a completely different disease compared with conventional head and neck cancers. Our objective was to analyze a surgically treated cohort to determine predictors of outcome in HPV-positive versus HPV-negative patients.HPV positivity was inferred based on p16-immunohistochemistry. Data was available for 201 patients with OPC treated with surgical resection with/without adjuvant radiotherapy between 1985 and 2005. Subsite distribution was: 66 (33 %) tonsil, 46 (23 %) soft palate, and 89 (44 %) tongue base. Patients were classified into low-, intermediate-, and high-risk groups based on p16 status and smoking history. Outcomes stratified by p16 status and risk groups were determined by the Kaplan-Meier method. Factors predictive of outcome were determined by univariate and multivariate analyses.In this cohort, 30 % had locally advanced disease (pT3/T4) and 71 % had nodal metastasis. The 5-year overall (OS), disease-specific, and recurrence-free survival rates were 60, 76, and 66 %, respectively. There were 22 % low-, 34 % intermediate-, and 44 % high-risk patients. Patients who were p16-positive had better survival compared with p16-negative (OS, 74 vs. 44 %; p.001). Similarly, low-risk group patients had a better survival compared with intermediate- and high-risk groups (OS, 76, 68, 45 %, respectively, p.001). Independent predictors of survival in p16-negative patients included margin status, lymphovascular invasion, pN status, and extracapsular spread. In contrast, none of these were predictive in p16-positive patients.Surgically treated patients with p16-positive OPC have superior survival compared with p16-negative patients. Outcomes in p16-positive and p16-negative OPC are determined by different prognostic factors supporting the notion that these are very different diseases. These should be incorporated into future clinical trials design.
- Published
- 2015
11. Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer
- Author
-
Ashok R. Shaha, Ian Ganly, Iain J. Nixon, Laura Y. Wang, Snehal G. Patel, Frank L. Palmer, Jatin P. Shah, and R. Michael Tuttle
- Subjects
Adult ,Oncology ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Disease-Free Survival ,Article ,Papillary thyroid cancer ,Iodine Radioisotopes ,Young Adult ,Surgical oncology ,Internal medicine ,medicine ,Humans ,In patient ,Thyroid Neoplasms ,Young adult ,Child ,Lymph node ,Survival rate ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Carcinoma ,Age Factors ,Retrospective cohort study ,Neck dissection ,Middle Aged ,Prognosis ,medicine.disease ,Tumor Burden ,Survival Rate ,medicine.anatomical_structure ,ROC Curve ,Child, Preschool ,Lymphatic Metastasis ,Neck Dissection ,Surgery ,Lymph Nodes ,business ,Neck ,Follow-Up Studies - Abstract
To identify lateral lymph node (LN) characteristics predictive of outcome in papillary thyroid cancer patients with clinically evident nodal disease.A total of 438 patients with lateral neck metastases from papillary thyroid cancer were identified from an institutional database of 3,664 differentiated thyroid cancers. The number of positive LNs, size of the largest LN, number of positive LNs to total number of LNs removed (LN burden), and presence of extranodal spread (ENS) were recorded. Cutoffs for continuous variables were determined by receiver operating characteristic curves. LN variables predictive of recurrence free survival and disease-specific survival (DSS) were identified by the Kaplan-Meier method and the Cox proportional hazard model.The median age was 41 years (range 5-86 years). The median follow-up was 65 months (range 1-332 months). Fifty-nine patients developed disease recurrence; these were local in five, regional in 40, and distant in 30 patients. Fifteen patients died of disease. Receiver operating characteristic cutoffs were10 positive LNs and a LN burden17 %. No lateral LN characteristics were predictive of DSS. In patients45 years old, univariate predictors of recurrence were10 positive nodes (p = 0.049) and LN burden17 % (p0.001). In patients ≥45 years old,10 positive nodes, LN burden17 %, and presence of ENS were predictive of recurrence (p = 0.019, p = 0.019, and p = 0.029, respectively).LN burden17 % (1 positive LN in 6 LNs removed) in the lateral neck is predictive for recurrence in patients of all ages, whereas ENS is also prognostic for recurrence in older patients.
- Published
- 2015
12. Treatment of the Neck in Carcinoma of the Parotid Gland
- Author
-
Snehal G. Patel, Ian Ganly, Safina Ali, Monica DiLorenzo, Frank L. Palmer, and Jatin P. Shah
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Adenocarcinoma ,Surgical oncology ,medicine ,Carcinoma ,Chi-square test ,Humans ,Pathological ,Aged ,Neoplasm Staging ,business.industry ,Histology ,Neck dissection ,Middle Aged ,Prognosis ,medicine.disease ,Occult ,Parotid Neoplasms ,Parotid gland ,Surgery ,medicine.anatomical_structure ,Oncology ,Elective Surgical Procedures ,Neck Dissection ,Female ,Neoplasm Grading ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
To review our experience in the treatment of the neck in patients with carcinoma of the parotid gland. A total of 263 patients were stratified into 3 groups: no neck dissection (NoND), elective neck dissection (END), and therapeutic neck dissection (TND). Clinicopathological characteristics of END and TND versus NoND were compared by Chi square test. Pathological positivity of each neck level was quantified. Neck recurrence–free survival was determined by Kaplan–Meier statistics. There were 232 cN0 and 31 cN+ patients. Of the cN0 patients, 74 had END. All cN+ patients had TND. Of the END group, occult neck metastases were detected in 26 (35 %) patients. The percentage of positivity was 6.7, 28.3, 21.3, 10.8, and 6.7 % for levels I to V, respectively. Compared to the NoND group, the END group was more likely to be over 60 years old, to have cT3T4 disease, and to have disease with more aggressive histology. Of the TND group, pathological positivity was found in 87 %. The percentage of positivity was 51.6, 77, 73, 53, and 40 % for levels I to V, respectively. Patients who had disease-positive necks had a poorer neck recurrence-free survival of 84.8 %. In patients with cN0 disease, observation of the neck is safe in those who are under 60 years of age with clinical T1 or T2 tumors and who have low-grade histology. END should be carried out in patients with cT3T4 disease or high-grade histology and should involve levels II to IV at a minimum. Patients with cN+ disease commonly have all neck levels involved and therefore should be managed with comprehensive neck dissection.
- Published
- 2014
13. Cause-Specific Mortality in Patients with Mucoepidermoid Carcinoma of the Major Salivary Glands
- Author
-
Jatin P. Shah, Monica M. Whitcher, Snehal G. Patel, Ian Ganly, Safina Ali, Mohammed Sarhan, and Frank L. Palmer
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Adolescent ,Kaplan-Meier Estimate ,Gastroenterology ,Disease-Free Survival ,Young Adult ,Mucoepidermoid carcinoma ,Cause of Death ,Major Salivary Gland ,Internal medicine ,Carcinoma ,Humans ,Medicine ,Neoplasm Metastasis ,Child ,Survival rate ,Aged ,Cause of death ,Aged, 80 and over ,Univariate analysis ,business.industry ,Incidence ,Incidence (epidemiology) ,Cancer ,Middle Aged ,Salivary Gland Neoplasms ,medicine.disease ,Survival Rate ,Oncology ,Carcinoma, Mucoepidermoid ,Female ,Surgery ,Neoplasm Grading ,Neoplasm Recurrence, Local ,business - Abstract
The objective of this study was to determine the incidence and cause of disease-specific death in patients with mucoepidermoid carcinoma (MEC) affecting the major salivary glands. A total of 94 patients with MEC treated at Memorial Sloan-Kettering Cancer Center between 1985 and 2009 were identified from a preexisting database of 451 patients with major salivary gland cancer. Patient, tumor, and treatment characteristics were recorded from a retrospective analysis of patient charts. There were 49 males (52 %), and the median age was 57 years (range, 9–89 years). Of the 94 patients, 49 % had low, 22 % had intermediate, and 28 % had high-grade carcinoma. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) were calculated using the Kaplan–Meier method. Cause of death was determined by chart review. Predictors of DSS were identified by univariate analysis. With a median follow-up of 59 months (range, 1–257), the 5-year OS, DSS, and RFS for all patients were 76 %, 83 %, and 79 %, respectively. DSS was significantly poorer for high-grade MEC compared with low/intermediate-grade MEC (5-year DSS 37 % vs 100 %, P
- Published
- 2013
14. The Role of Sentinel Lymph Node Biopsy in the Management of Head and Neck Desmoplastic Melanoma
- Author
-
Jatin P. Shah, Dennis H. Kraus, Ian Ganly, Klaus J. Busam, Arash Mohebati, Daniel G. Coit, and Snehal G. Patel
- Subjects
Male ,Oncology ,medicine.medical_specialty ,Skin Neoplasms ,Lymphovascular invasion ,Sentinel lymph node ,Breslow Thickness ,Internal medicine ,Biopsy ,medicine ,Humans ,Melanoma ,Aged ,Neoplasm Staging ,Retrospective Studies ,Desmoplastic melanoma ,medicine.diagnostic_test ,Sentinel Lymph Node Biopsy ,business.industry ,Disease Management ,Cancer ,Prognosis ,medicine.disease ,Survival Rate ,Head and Neck Neoplasms ,Female ,Surgery ,Radiology ,business ,Follow-Up Studies ,Spindle Cell Melanoma - Abstract
Desmoplastic melanoma (DM), a variant of spindle cell melanoma, has a higher propensity for local recurrence and a lower incidence of nodal metastasis. In this retrospective review, we evaluated the risk for regional nodal metastases and the need for sentinel lymph node biopsy (SLNB) in patients with head and neck DM. We identified 103 patients with DM from an institutional database of patients with head and neck melanomas treated between 1985 and 2009. Forty-seven patients had their primary treatment at Memorial Sloan-Kettering Cancer Center, and 56 patients were treated for recurrent or metastatic disease. Of the 47 study patients, 27 were men and 20 were women with a median age of 71 years. All patients underwent wide excision, and 21 (44 %) underwent SLNB. None of the patients who underwent SLNB had positive nodes. The mean Breslow thickness for the 45 reported patients was 6.1 mm, with 84 % of tumors >2 mm in thickness and 55 % >4 mm. All known Clark thickness levels (n = 40) were IV or V. The overall survival was 73 %, with disease-specific survival of 84 %, local recurrence-free survival of 75 %, and neck recurrence-free survival of 97 % at 5 years. Although DM is diagnosed at higher Breslow thickness and Clark level, neck metastases are rare and prognosis is favorable compared to conventional melanoma. The low incidence of lymphovascular invasion, high frequency of histopathologically negative sentinel lymph nodes, and low neck recurrence rates indicate that staging of neck disease by SLNB is not necessary in patients with pure DM of the head and neck.
- Published
- 2012
15. Surgical Management of Metastases to the Thyroid Gland
- Author
-
Snehal G. Patel, Jatin P. Shah, Monica M. Whitcher, Joelle Glick, Frank L. Palmer, Ian Ganly, Iain J. Nixon, and Ashok R. Shaha
- Subjects
Adult ,Male ,endocrine system ,medicine.medical_specialty ,endocrine system diseases ,medicine.medical_treatment ,stomatognathic system ,Surgical oncology ,Renal cell carcinoma ,Neoplasms ,medicine ,Humans ,Thyroid Neoplasms ,Survival rate ,Aged ,Retrospective Studies ,Aged, 80 and over ,Total thyroidectomy ,business.industry ,General surgery ,Thyroid ,Thyroidectomy ,Retrospective cohort study ,Middle Aged ,Neoplasms surgery ,medicine.disease ,Survival Rate ,Treatment Outcome ,medicine.anatomical_structure ,Oncology ,Female ,Surgery ,Radiology ,business - Abstract
Metastases to the thyroid gland are uncommon, with rates reported between 0.02% and 1.4% of surgically resected thyroid specimens. Our goal was to present our experience with surgical management of metastases to the thyroid gland.Twenty-one patients with metastatic disease to the thyroid were identified from a database of 1,992 patients with thyroid cancer who had surgery during 1986-2005. Patient, tumor, treatment, and outcome details were recorded by analysis of charts. The median age at time of surgery was 68 (range, 39-83) years; 12 were men and 9 were women.All patients were managed by surgery, including lobectomy in ten patients, total thyroidectomy in six, completion thyroidectomy in two, and subtotal thyroidectomy in one. In two patients, the thyroid lesion was found to be unresectable at the time of surgery. Histopathology revealed renal cell carcinoma in ten, malignant melanoma in three, gastrointestinal adenocarcinoma in three, breast cancer in one, sarcoma in one, and adenocarcinoma from an unknown primary site in three patients. Seventeen patients have died. The cause of death in all 17 was widespread metastatic disease from their respective primary tumors. The median survival from surgery to death or last follow-up was 26.5 (range, 2-114) months.In patients with metastases to the thyroid gland, local control of metastatic disease in the central compartment of the neck can be successfully achieved with minimal morbidity with surgical resection in selected patients.
- Published
- 2010
16. Electronic Synoptic Operative Reporting for Thyroid Surgery using an Electronic Data Management System: Potential for Prospective Multicenter Data Collection
- Author
-
Ian Ganly, Snehal G. Patel, Ashok R. Shaha, N. Gopalakrishna Iyer, Frank L. Palmer, and Iain J. Nixon
- Subjects
medicine.medical_specialty ,Medical Records Systems, Computerized ,Pilot Projects ,Thyroid Lobectomy ,Documentation ,Operative report ,Humans ,Medicine ,Prospective Studies ,Thyroid Neoplasms ,Thyroid cancer ,Retrospective Studies ,Data collection ,business.industry ,Thyroid ,Prognosis ,medicine.disease ,Surgery ,Survival Rate ,medicine.anatomical_structure ,Oncology ,Management system ,Thyroidectomy ,Electronic data ,business - Abstract
Electronic synoptic operative reports ensure systematic documentation of all critical components and findings during complex surgical procedures. Thyroid surgery lends itself to synoptic reporting, because there are a predefined number of essential intraoperative events and findings that every endocrine surgeon invariably records.An electronic web-based form (e-form) was designed and implemented to record operative data in a synoptic structure for thyroid surgery. The e-form was implemented as a pilot study from January 2008 to October 2009 for use by three attending surgeons.During this period, 514 e-forms were completed with 100% compliance, which recorded data from 384 total thyroidectomies and 130 thyroid lobectomies. All users found the e-form to be easy to use, comprehensive, and took less than 5 min to complete.The main advantages of a web-based e-form for synoptic recording of thyroid surgery are that it is user-friendly and easy to complete, yet comprehensive. Because it is based on a system available across institutions, it can be used as a minimum dataset and could be considered a national and international standard for wider use, especially if endorsed by the American or International Association for Endocrine Surgeons.
- Published
- 2010
17. Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
- Author
-
Ashok R. Shaha, Snehal G. Patel, Monica M. Whitcher, Jatin P. Shah, Ian Ganly, Iain J. Nixon, and Frank L. Palmer
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Postoperative Complications ,Adenocarcinoma, Follicular ,medicine ,Recurrent laryngeal nerve ,Carcinoma ,Humans ,Thyroid Neoplasms ,Thyroid cancer ,Survival rate ,Aged ,Aged, 80 and over ,Solitary pulmonary nodule ,Recurrent Laryngeal Nerve ,business.industry ,General surgery ,Thyroid ,Thyroidectomy ,Cell Differentiation ,Middle Aged ,Prognosis ,medicine.disease ,Carcinoma, Papillary ,Survival Rate ,medicine.anatomical_structure ,Oncology ,Thyroid isthmus ,Female ,Surgery ,Radiology ,Neoplasm Recurrence, Local ,business ,Vocal Cord Paralysis ,Follow-Up Studies - Abstract
Background The American Thyroid Association guidelines do not mention isthmusectomy as an appropriate procedure for thyroid cancer. Despite this, a small number of patients present with lesions isolated to the thyroid isthmus, which can be excised without exploring the trachyesophageal grooves or total thyroidectomy. This study was designed to analyze outcomes in patients treated with isthmusectomy for small well-differentiated thyroid cancer (WDTC) at our institution. Methods Nineteen patients with WDTC managed by isthmusectomy were identified from a database of 1,810 patients (1%) with WDTC managed by surgery in Memorial Sloan Kettering Cancer Center from 1986-2005. Demographic, surgical, pathological, and outcomes data were analyzed. Results Six patients were men and 13 were women. The median age was 46 (range, 28-83) years. All patients had a solitary nodule confined to the thyroid isthmus. The median size of lesion was 1 (range, 0.4-3) cm. Eighteen patients had a pathologically T1 lesion (pT1), and one patient had a pT2 lesion. Two patients had papillary carcinoma detected in perithyroid lymph nodes (pN1a). There were no complications of recurrent laryngeal nerve palsy or hypocalcaemia. With a median follow-up of 124 (range, 53-276) months, the 10-year disease-specific survival was 100% and 100% local and regional 10-year recurrence-free survival. Conclusions Our results suggest that isthmusectomy alone may be sufficient treatment for selected patients with small WDTC limited to the isthmus. This procedure has the benefit of avoiding dissection of the recurrent laryngeal nerve and parathyroid glands, thus limiting postoperative complications.
- Published
- 2010
18. Distant Metastases in Patients with Carcinoma of the Major Salivary Glands
- Author
-
Ian Ganly, Jatin P. Shah, Frank L. Palmer, Snehal G. Patel, Monica DiLorenzo, Safina Ali, and Robert Bryant
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Adolescent ,Article ,Sublingual Gland Neoplasm ,Young Adult ,Sex Factors ,Surgical oncology ,Risk Factors ,Major Salivary Gland ,Carcinoma ,medicine ,Humans ,Neoplasm Invasiveness ,Child ,Aged ,Neoplasm Staging ,Probability ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Incidence (epidemiology) ,Sublingual Gland Neoplasms ,Histology ,Middle Aged ,medicine.disease ,Parotid Neoplasms ,Submandibular Gland Neoplasms ,Oncology ,Salivary gland cancer ,Submandibular Gland Neoplasm ,Surgery ,Female ,Neoplasm Grading ,business - Abstract
This study aimed to show the incidence of distant metastases (DM) in salivary gland cancer as well as the types of histology most commonly associated with it and to identify factors predictive of DM.The study identified 301 patients who underwent surgery for cancer of the major salivary glands at Memorial Sloan-Kettering Cancer center between 1985 and 2009. Clinical, tumor, and treatment characteristics were recorded. Tumors were categorized as low-, intermediate-, and high-risk pathology based on histologic subtype and grade. Factors predictive of distant recurrence-free probability (DRFP) were determined by uni- and multivariable analyses.The primary tumor was parotid in 266 patients (88 %), and 96 tumors (32 %) were clinical T3/T4. For 57 patients (18.9 %), DM developed with a 5-year DRFP of 72.7 %. The most common site of metastasis was the lung (50 %). The clinical predictors were male gender, cT4 stage, cN+ stage, and clinical overall stage. The multivariable analysis of clinical variables showed male gender (p = 0.018), cT4 stage (p0.001), and cN+ stage (p = 0.004) to be significant. The pathologic predictors were high-risk and high-grade pathology, vascular invasion, perineural invasion, positive margins, pT4 stage, pN+ stage, and overall stage. The multivariable analysis of pathologic variables showed high-grade pathology (p0.001), perineural invasion (p = 0.005), and pN+ stage (p = 0.002) to be significant.Distant metastases developed in approximately 20 % of the patients with salivary gland cancer. The most common site of metastases was the lung. The significant predictors of DM were cT4, cN+, male gender, high-grade pathology, perineural invasion, and positive nodal disease.
- Published
- 2014
19. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer
- Author
-
Frank L. Palmer, Michael W. Kattan, R. Michael Tuttle, Changhong Yu, Allen S. Ho, Lu Wang, Snehal G. Patel, Ian Ganly, and Arnbjorn Toset
- Subjects
Oncology ,Adult ,Calcitonin ,Male ,endocrine system ,medicine.medical_specialty ,Pathology ,endocrine system diseases ,medicine.medical_treatment ,Article ,Sex Factors ,Predictive Value of Tests ,Internal medicine ,medicine ,Humans ,Neoplasm Invasiveness ,Postoperative Period ,Thyroid Neoplasms ,Survival rate ,Thyroid cancer ,Aged ,Neoplasm Staging ,business.industry ,Thyroid ,Age Factors ,Medullary thyroid cancer ,Neck dissection ,Nomogram ,Middle Aged ,medicine.disease ,Carcinoma, Neuroendocrine ,Survival Rate ,Nomograms ,medicine.anatomical_structure ,Predictive value of tests ,Lymphatic Metastasis ,Multivariate Analysis ,Blood Vessels ,Surgery ,Female ,business ,Follow-Up Studies - Abstract
Medullary thyroid cancer (MTC) is a rare thyroid cancer accounting for 5 % of all thyroid malignancies. The purpose of our study was to design a predictive nomogram for cancer-specific mortality (CSM) utilizing clinical, pathological, and biochemical variables in patients with MTC.MTC patients managed entirely at Memorial Sloan-Kettering Cancer Center between 1986 and 2010 were identified. Patient, tumor, and treatment characteristics were recorded, and variables predictive of CSM were identified by univariable analyses. A multivariable competing risk model was then built to predict the 10-year cancer specific mortality of MTC. All predictors of interest were added in the starting full model before selection, including age, gender, pre- and postoperative serum calcitonin, pre- and postoperative CEA, RET mutation status, perivascular invasion, margin status, pathologic T status, pathologic N status, and M status. Stepdown method was used in model selection to choose predictive variables.Of 249 MTC patients, 22.5 % (56/249) died from MTC, whereas 6.4 % (16/249) died secondary to other causes. Mean follow-up period was 87 ± 67 months. The seven variables with the highest predictive accuracy for cancer specific mortality included age, gender, postoperative calcitonin, perivascular invasion, pathologic T status, pathologic N status, and M status. These variables were used to create the final nomogram. Discrimination from the final nomogram was measured at 0.77 with appropriate calibration.We describe the first nomogram that estimates cause-specific mortality in individual patients with MTC. This predictive nomogram will facilitate patient counseling in terms of prognosis and subsequent clinical follow up.
- Published
- 2014
20. Level 7 disease does not confer worse outcome than level 6 disease in differentiated thyroid cancer
- Author
-
Iain J. Nixon, Ashok R. Shaha, Ian Ganly, Dorothy Thomas, Frank L. Palmer, Jatin P. Shah, Snehal G. Patel, Laura Y. Wang, and R. Michael Tuttle
- Subjects
Oncology ,Adult ,Male ,medicine.medical_specialty ,Adolescent ,Disease ,Nodal disease ,Disease-Free Survival ,Young Adult ,Surgical oncology ,Internal medicine ,Medicine ,Humans ,Thyroid Neoplasms ,Stage (cooking) ,Child ,Thyroid cancer ,Aged ,Aged, 80 and over ,business.industry ,Thyroid ,Cancer ,Middle Aged ,medicine.disease ,Survival Analysis ,Surgery ,Background level ,medicine.anatomical_structure ,Lymphatic Metastasis ,Female ,Neoplasm Recurrence, Local ,business - Abstract
Level 7 nodal disease increases patients from N1a to N1b in the American Joint Committee on Cancer (AJCC) TNM classification of differentiated thyroid cancers (DTCs). This results in upstaging of patients older than 45 years of age from stage III to IV. Our objective was to determine if patients with level 7 disease had poorer outcome in comparison to patients with isolated level 6 disease.A total of 599 patients with DTC limited to the central neck (level 6 and 7) were identified from an institutional database. Patients with N1b disease due to lateral compartment (level 1-5) involvement or M1 disease were excluded. Fifty-seven patients had positive level 7 disease, and 542 patients had nodal disease limited to level 6. Disease-specific survival (DSS) and recurrence-free survival (RFS) were calculated for each group.Median age was 41 years (range 12-91) and follow-up was 61 months (range 1-330). There were no disease-specific deaths at 5 years. Among patients with level 6 disease at presentation, there were 42 nodal recurrences, and among patients with level 7 disease, there were two recurrences. There were no differences in overall RFS between patients with level 6 or 7 disease (5-year RFS 90.7 vs. 98.2 %, respectively; p = 0.096).Our results suggest that N1b disease due to level 7 disease does not confer worse DSS or RFS compared with patients with level 6 disease only. Classifying all central neck disease (levels 6 and 7) into the N1a category, and reserving the N1b classification only for patients with lateral neck disease may be more reflective of prognosis.
- Published
- 2014
21. Anaplastic thyroid carcinoma: a 25-year single-institution experience
- Author
-
Jatin P. Shah, Snehal G. Patel, Nancy Y. Lee, Ian Ganly, Monica DiLorenzo, David G. Pfister, Ashok R. Shaha, R. M. Tuttle, Frank L. Palmer, and Arash Mohebati
- Subjects
Oncology ,Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Thyroid Carcinoma, Anaplastic ,Thyroid carcinoma ,Surgical oncology ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Thyroid Neoplasms ,Survival rate ,Aged ,Neoplasm Staging ,Retrospective Studies ,Aged, 80 and over ,Radiotherapy ,business.industry ,Thyroid ,Thyroidectomy ,Retrospective cohort study ,Middle Aged ,Prognosis ,Combined Modality Therapy ,Clinical trial ,Radiation therapy ,Survival Rate ,medicine.anatomical_structure ,Surgery ,Female ,business ,Follow-Up Studies - Abstract
Anaplastic thyroid carcinoma (ATC) is among the most aggressive solid tumors accounting for 1-5 % of primary thyroid malignancies. In this retrospective review, we aim to evaluate the prognostic factors, treatment approaches, and outcomes of patients with ATC treated at a single institution.We retrospectively identified 95 patients with ATC from an institutional database between 1985 and 2010. A total of 83 patients with sufficient records were included in this study. Patient, tumor, and treatment characteristics were recorded. Disease-specific survival (DSS) was determined by the Kaplan-Meier method, and factors predictive of outcome were determined by univariate and multivariate analysis.Of the 83 patients, 41 were male and 42 were female. The median age at presentation was 60 years (range 28-89 years) with a median survival of 8 months. The 1- and 2-year DSS were 33 and 23 %, respectively. On univariate analysis, age less than 60 years, clinically N0 neck, absence of clinical extrathyroidal extension (cETE), gross total resection, and multimodality treatment were statistically significant predictors of improved survival. On multivariate analysis, absence of cETE, multimodality therapy, and gross total resection were predictors of improved outcome.In patients with locoregional limited disease, multimodality treatment with gross total surgical resection and postoperative radiotherapy with or without chemotherapy offers the best local control and DSS.
- Published
- 2013
22. Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinoma
- Author
-
Frank L. Palmer, A. Shaha, Ian Ganly, R. Michael Tuttle, Brian R. Untch, Jatin P. Shah, and Snehal G. Patel
- Subjects
Adult ,Male ,medicine.medical_specialty ,Thyroid Lobectomy ,Adenocarcinoma ,Thyroid carcinoma ,Postoperative Complications ,Surgical oncology ,Multifocal disease ,Risk Factors ,Adenocarcinoma, Follicular ,Medicine ,Humans ,Thyroid Neoplasms ,Neoplasm Staging ,Retrospective Studies ,Completion thyroidectomy ,business.industry ,Thyroid ,Prognosis ,Carcinoma, Papillary ,Surgery ,medicine.anatomical_structure ,Oncology ,Thyroidectomy ,Female ,Neoplasm Recurrence, Local ,business ,Intermediate risk ,Well Differentiated Thyroid Carcinoma ,Follow-Up Studies - Abstract
At our institution, thyroid lobectomy is employed as a definitive operation for unifocal intrathyroidal low risk cancers and thus completion thyroidectomy is rarely performed. The purpose of this study was to identify the indications for selective completion thyroidectomy and to report oncologic outcomes. A retrospective review was performed to identify patients who underwent planned completion thyroidectomy for well-differentiated thyroid carcinoma (WDTC) from 2001 to 2010 based on initial lobectomy pathology. Assessment for risk of recurrence was based on the American Thyroid Association Initial Risk Stratification. During the 10-year study period, 79 patients underwent completion thyroidectomy for WDTC. Forty-four (56 %) patients were low risk and 35 (44 %) were intermediate risk. Completion thyroidectomy was recommended for 64 patients, whereas 15 patients were given an option of surveillance but ultimately decided to have surgery. Patients in the “recommended group” had more T3 tumors and fewer T1a tumors (p = 0.005 and 0.006, respectively). These patients also were more likely to be intermediate risk (p = 0.008) and to present with aggressive histology (p = 0.002). The rate of contralateral tumors (n = 27) was similar between both groups (35 and 33 %, respectively). Contralateral cancers were micropapillary in 24 of 27 (89 %) patients, 10 (40 %) of whom had multifocal disease. There were two pulmonary recurrences and no local-regional recurrences (median follow-up of 42.3 months). Completion thyroidectomy is infrequent and performed for a select group of intermediate and low risk WDTCs at our institution with low recurrence rates. Incidental multifocal and unifocal contralateral cancers are common after completion thyroidectomy.
- Published
- 2013
23. Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands
- Author
-
Snehal G. Patel, Safina Ali, Michael W. Kattan, Ian Ganly, Changhong Yu, Monica DiLorenzo, Jatin P. Shah, and Frank L. Palmer
- Subjects
Oncology ,Adult ,Male ,medicine.medical_specialty ,genetic structures ,Adolescent ,Adenoid cystic carcinoma ,Perineural invasion ,urologic and male genital diseases ,Young Adult ,Postoperative Complications ,Surgical oncology ,Internal medicine ,Major Salivary Gland ,medicine ,Humans ,Neoplasm Invasiveness ,Stage (cooking) ,Child ,Aged ,Neoplasm Staging ,Aged, 80 and over ,Univariate analysis ,business.industry ,Nomogram ,Middle Aged ,medicine.disease ,Prognosis ,Salivary Gland Neoplasms ,Surgery ,Survival Rate ,Nomograms ,Salivary gland cancer ,Female ,Neoplasm Grading ,business ,Follow-Up Studies - Abstract
The objective of this study was to create a nomogram predictive of survival in salivary gland cancer. Clinical, tumor, and treatment characteristics were collected for 301 patients who underwent surgery for salivary gland cancer between 1985 and 2009 at Memorial Sloan Kettering Cancer Centre. Factors predictive of overall survival (OS) and cancer-specific survival (CSS) were determined by univariate analysis. Cox risk regression was used to model OS data. Competing risks regression was used for cancer-specific death. Deaths from other causes were treated as competing risks for cancer-specific death. Predictive nomograms for OS and CSS were then created using stepdown method to select predictors of outcome. The median age was 62 (range 9–89) years. There were 156 (52 %) males and 145 (48 %) females. Five variables predictive for OS (age, clinical T4 stage, histological grade, perineural invasion, and tumor dimension) were used to generate a parsimonious model, and a nomogram was created to predict 10-year survival probability. The concordance index (CI) for this nomogram was 0.809. Five variables predictive for CSS (histological grade, perineural invasion, clinical T4 stage, positive nodal status, and status of margins) were used to generate a second nomogram predicting CSS. This nomogram had a CI of 0.856. Both nomograms were validated internally by assessing discrimination and calibration. We have developed the first nomograms to predict prognosis in an individual patient with salivary gland cancer.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.